0
Upcoming Allied Market Research
2023
Ophthalmology Diagnostics And Surgical Devices Market

Ophthalmology Diagnostics and Surgical Devices Market

by  Diagnostic (Autorefractometers, Slit Lamps, Tonometers, Ophthalmoscopes, Fundus Cameras, Optical Coherence Tomography, Others), by  Surgical (Vitreoretinal Surgery, Cataract Surgery, Glaucoma Surgery, Refractive Surgery) and by Vision Care (Contact Lens, Spectacles Lenses): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A12302
Nov 2023 | Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Ophthalmology Diagnostics And Surgical Devices Market

Request Now !

Ophthalmology is a branch of medicine that deals with the treatment, diagnosis, and prevention of diseases of the visual system and the eye. The visual system, the eye, and its surrounding structures can be affected by a variety of clinical conditions. Ophthalmology involves the therapy and diagnosis of these conditions along with microsurgery. The different types of ophthalmology surgeries are vitreoretinal surgery, cataract surgery, glaucoma surgery, and refractive surgery. In addition, the devices used in ophthalmology diagnostics include auto refractometers, slit lamps, and tonometers.

COVID-19 Impact Analysis

COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing a shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness significant growth in the future, owing to the demand for vaccines and treatment drugs for COVID-19.

With COVID-19 the supply chain of raw materials required to manufacture ophthalmology diagnostics and surgical devices has been disrupted in many countries. In addition, the market growth of ophthalmology diagnostics and surgical devices is declining as manufacturers of these devices have slowed down their production due to the pandemic. Therefore, COVID 19 is expected to have a significant impact on the ophthalmology diagnostics and surgical devices market.

Top Impacting Factors

The rising cases of various ocular disorders such as age-related macular degeneration, diabetic retinopathy, cataract, and amblyopia is a key factor that boosts the market of ophthalmology diagnostics and surgical devices.

Furthermore, the rising geriatric population all across the world is supplementing the growth of the ophthalmology diagnostics and surgical devices market. This is attributed to the fact that the elderly population is at risk of developing ocular disorders such as glaucoma.

In addition, many patients with weak vision are now opting for laser-assisted in-situ keratomileusis (LASIK) procedures for their vision correction. This factor is hence majorly contributing to the growth of the market.

However, high cost of ophthalmology surgical systems and intraoperative ophthalmic imaging can impede the growth of the ophthalmology diagnostics and surgical devices market.

Key Market Trends

The ophthalmology diagnostics and surgical devices market is witnessing development in intraoperative optical tomography (iOCT). For instance, in 2019 a study published in the journal of Ophthalmic and Vision Research found that iOCT can help explant a dislocated intraocular lens without retinal breaks.

In September 2018, a study published in the journal Retina found that the 4K screen offers better visualization of optical coherence tomography data stream as compared to the semi-transparent ocular view. The integration of OCT in a digital visualization system may enhance vitreoretinal diagnostics and surgery.

Major players of the ophthalmology diagnostics and surgical devices market are focused on launching new products and services to expand their product portfolio. For instance, Alcon Laboratories, Inc. launched a program in May 2020 to help professionals understand the benefits of treating meibomian gland dysfunction, which is the major cause of evaporative dry eye.

North America holds the major share of the ophthalmology diagnostics and surgical devices market, owing to the presence of high penetration of technologically advanced medical devices and improved healthcare facilities for better diagnosis of ophthalmic disorders.

Key Benefits of the Report

  • This study presents the analytical depiction of the ophthalmology diagnostics and surgical devices industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the market share.
  • The current market is quantitatively analyzed to highlight the growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Ophthalmology Diagnostics and Surgical Devices Report

  • Which are the leading players active in the ophthalmology diagnostics and surgical devices market?
  • How is each segment of the market expected to grow during the forecast period?
  • What are the adoption trends for the ophthalmology diagnostics and surgical devices market in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps in the market?
  • What are the impacts of COVID-19 on the industry?
  • What are ophthalmology diagnostics and surgical devices?
  • What are the current and predicted trends of the market?

Ophthalmology Diagnostics and Surgical Devices Market Report Highlights

Aspects Details
By  Diagnostic
  • Autorefractometers
  • Slit Lamps
  • Tonometers
  • Ophthalmoscopes
  • Fundus Cameras
  • Optical Coherence Tomography
  • Others
By  Surgical
  • Vitreoretinal Surgery
  • Cataract Surgery
  • Glaucoma Surgery
  • Refractive Surgery
By Vision Care
  • Contact Lens
  • Spectacles Lenses
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Carl Zeiss Meditec AG, Hoya Corporation, Alcon Laboratories, Inc., Abbott Medical Optics, Inc., Topcon Corporation, Essilor International, SynergEyes, Johnson and Johnson, CooperVision, Bausch & Lomb, Inc.
 
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET, BY  DIAGNOSTIC

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By  diagnostic

    • 4.2. Autorefractometers

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Slit Lamps

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Tonometers

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Ophthalmoscopes

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Fundus Cameras

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

    • 4.7. Optical Coherence Tomography

      • 4.7.1. Key Market Trends, Growth Factors and Opportunities

      • 4.7.2. Market Size and Forecast, By Region

      • 4.7.3. Market Share Analysis, By Country

    • 4.8. Others

      • 4.8.1. Key Market Trends, Growth Factors and Opportunities

      • 4.8.2. Market Size and Forecast, By Region

      • 4.8.3. Market Share Analysis, By Country

  • CHAPTER 5: OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET, BY  SURGICAL

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By  surgical

    • 5.2. Vitreoretinal Surgery

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Cataract Surgery

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Glaucoma Surgery

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Refractive Surgery

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET, BY VISION CARE

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Vision Care

    • 6.2. Contact Lens

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Spectacles Lenses

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

  • CHAPTER 7: OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By  diagnostic

      • 7.2.3. Market Size and Forecast, By  surgical

      • 7.2.4. Market Size and Forecast, By Vision Care

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Ophthalmology Diagnostics And Surgical Devices Market

        • 7.2.6.1. Market Size and Forecast, By  diagnostic
        • 7.2.6.2. Market Size and Forecast, By  surgical
        • 7.2.6.3. Market Size and Forecast, By Vision Care
      • 7.2.7. Canada Ophthalmology Diagnostics And Surgical Devices Market

        • 7.2.7.1. Market Size and Forecast, By  diagnostic
        • 7.2.7.2. Market Size and Forecast, By  surgical
        • 7.2.7.3. Market Size and Forecast, By Vision Care
      • 7.2.8. Mexico Ophthalmology Diagnostics And Surgical Devices Market

        • 7.2.8.1. Market Size and Forecast, By  diagnostic
        • 7.2.8.2. Market Size and Forecast, By  surgical
        • 7.2.8.3. Market Size and Forecast, By Vision Care
    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By  diagnostic

      • 7.3.3. Market Size and Forecast, By  surgical

      • 7.3.4. Market Size and Forecast, By Vision Care

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Ophthalmology Diagnostics And Surgical Devices Market

        • 7.3.6.1. Market Size and Forecast, By  diagnostic
        • 7.3.6.2. Market Size and Forecast, By  surgical
        • 7.3.6.3. Market Size and Forecast, By Vision Care
      • 7.3.7. Germany Ophthalmology Diagnostics And Surgical Devices Market

        • 7.3.7.1. Market Size and Forecast, By  diagnostic
        • 7.3.7.2. Market Size and Forecast, By  surgical
        • 7.3.7.3. Market Size and Forecast, By Vision Care
      • 7.3.8. Italy Ophthalmology Diagnostics And Surgical Devices Market

        • 7.3.8.1. Market Size and Forecast, By  diagnostic
        • 7.3.8.2. Market Size and Forecast, By  surgical
        • 7.3.8.3. Market Size and Forecast, By Vision Care
      • 7.3.9. Spain Ophthalmology Diagnostics And Surgical Devices Market

        • 7.3.9.1. Market Size and Forecast, By  diagnostic
        • 7.3.9.2. Market Size and Forecast, By  surgical
        • 7.3.9.3. Market Size and Forecast, By Vision Care
      • 7.3.10. UK Ophthalmology Diagnostics And Surgical Devices Market

        • 7.3.10.1. Market Size and Forecast, By  diagnostic
        • 7.3.10.2. Market Size and Forecast, By  surgical
        • 7.3.10.3. Market Size and Forecast, By Vision Care
      • 7.3.11. Russia Ophthalmology Diagnostics And Surgical Devices Market

        • 7.3.11.1. Market Size and Forecast, By  diagnostic
        • 7.3.11.2. Market Size and Forecast, By  surgical
        • 7.3.11.3. Market Size and Forecast, By Vision Care
      • 7.3.12. Rest Of Europe Ophthalmology Diagnostics And Surgical Devices Market

        • 7.3.12.1. Market Size and Forecast, By  diagnostic
        • 7.3.12.2. Market Size and Forecast, By  surgical
        • 7.3.12.3. Market Size and Forecast, By Vision Care
    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By  diagnostic

      • 7.4.3. Market Size and Forecast, By  surgical

      • 7.4.4. Market Size and Forecast, By Vision Care

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Ophthalmology Diagnostics And Surgical Devices Market

        • 7.4.6.1. Market Size and Forecast, By  diagnostic
        • 7.4.6.2. Market Size and Forecast, By  surgical
        • 7.4.6.3. Market Size and Forecast, By Vision Care
      • 7.4.7. Japan Ophthalmology Diagnostics And Surgical Devices Market

        • 7.4.7.1. Market Size and Forecast, By  diagnostic
        • 7.4.7.2. Market Size and Forecast, By  surgical
        • 7.4.7.3. Market Size and Forecast, By Vision Care
      • 7.4.8. India Ophthalmology Diagnostics And Surgical Devices Market

        • 7.4.8.1. Market Size and Forecast, By  diagnostic
        • 7.4.8.2. Market Size and Forecast, By  surgical
        • 7.4.8.3. Market Size and Forecast, By Vision Care
      • 7.4.9. South Korea Ophthalmology Diagnostics And Surgical Devices Market

        • 7.4.9.1. Market Size and Forecast, By  diagnostic
        • 7.4.9.2. Market Size and Forecast, By  surgical
        • 7.4.9.3. Market Size and Forecast, By Vision Care
      • 7.4.10. Australia Ophthalmology Diagnostics And Surgical Devices Market

        • 7.4.10.1. Market Size and Forecast, By  diagnostic
        • 7.4.10.2. Market Size and Forecast, By  surgical
        • 7.4.10.3. Market Size and Forecast, By Vision Care
      • 7.4.11. Thailand Ophthalmology Diagnostics And Surgical Devices Market

        • 7.4.11.1. Market Size and Forecast, By  diagnostic
        • 7.4.11.2. Market Size and Forecast, By  surgical
        • 7.4.11.3. Market Size and Forecast, By Vision Care
      • 7.4.12. Malaysia Ophthalmology Diagnostics And Surgical Devices Market

        • 7.4.12.1. Market Size and Forecast, By  diagnostic
        • 7.4.12.2. Market Size and Forecast, By  surgical
        • 7.4.12.3. Market Size and Forecast, By Vision Care
      • 7.4.13. Indonesia Ophthalmology Diagnostics And Surgical Devices Market

        • 7.4.13.1. Market Size and Forecast, By  diagnostic
        • 7.4.13.2. Market Size and Forecast, By  surgical
        • 7.4.13.3. Market Size and Forecast, By Vision Care
      • 7.4.14. Rest of Asia Pacific Ophthalmology Diagnostics And Surgical Devices Market

        • 7.4.14.1. Market Size and Forecast, By  diagnostic
        • 7.4.14.2. Market Size and Forecast, By  surgical
        • 7.4.14.3. Market Size and Forecast, By Vision Care
    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By  diagnostic

      • 7.5.3. Market Size and Forecast, By  surgical

      • 7.5.4. Market Size and Forecast, By Vision Care

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Ophthalmology Diagnostics And Surgical Devices Market

        • 7.5.6.1. Market Size and Forecast, By  diagnostic
        • 7.5.6.2. Market Size and Forecast, By  surgical
        • 7.5.6.3. Market Size and Forecast, By Vision Care
      • 7.5.7. South Africa Ophthalmology Diagnostics And Surgical Devices Market

        • 7.5.7.1. Market Size and Forecast, By  diagnostic
        • 7.5.7.2. Market Size and Forecast, By  surgical
        • 7.5.7.3. Market Size and Forecast, By Vision Care
      • 7.5.8. Saudi Arabia Ophthalmology Diagnostics And Surgical Devices Market

        • 7.5.8.1. Market Size and Forecast, By  diagnostic
        • 7.5.8.2. Market Size and Forecast, By  surgical
        • 7.5.8.3. Market Size and Forecast, By Vision Care
      • 7.5.9. UAE Ophthalmology Diagnostics And Surgical Devices Market

        • 7.5.9.1. Market Size and Forecast, By  diagnostic
        • 7.5.9.2. Market Size and Forecast, By  surgical
        • 7.5.9.3. Market Size and Forecast, By Vision Care
      • 7.5.10. Argentina Ophthalmology Diagnostics And Surgical Devices Market

        • 7.5.10.1. Market Size and Forecast, By  diagnostic
        • 7.5.10.2. Market Size and Forecast, By  surgical
        • 7.5.10.3. Market Size and Forecast, By Vision Care
      • 7.5.11. Rest of LAMEA Ophthalmology Diagnostics And Surgical Devices Market

        • 7.5.11.1. Market Size and Forecast, By  diagnostic
        • 7.5.11.2. Market Size and Forecast, By  surgical
        • 7.5.11.3. Market Size and Forecast, By Vision Care
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning,2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Bausch And Lomb, Inc.

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Carl Zeiss Meditec AG

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. CooperVision

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Essilor International

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Abbott Medical Optics, Inc.

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Alcon Laboratories, Inc.

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Hoya Corporation

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Johnson And Johnson

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Topcon Corporation

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. SynergEyes

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET FOR AUTOREFRACTOMETERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET FOR SLIT LAMPS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET FOR TONOMETERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET FOR OPHTHALMOSCOPES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET FOR FUNDUS CAMERAS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET FOR OPTICAL COHERENCE TOMOGRAPHY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET FOR VITREORETINAL SURGERY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET FOR CATARACT SURGERY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET FOR GLAUCOMA SURGERY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET FOR REFRACTIVE SURGERY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET FOR CONTACT LENS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET FOR SPECTACLES LENSES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 22. U.S. OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 23. U.S. OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 24. U.S. OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 25. CANADA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 26. CANADA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 27. CANADA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 28. MEXICO OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 29. MEXICO OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 30. MEXICO OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 31. EUROPE OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 32. EUROPE OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 33. EUROPE OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 34. EUROPE OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 35. FRANCE OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 36. FRANCE OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 37. FRANCE OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 38. GERMANY OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 39. GERMANY OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 40. GERMANY OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 41. ITALY OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 42. ITALY OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 43. ITALY OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 44. SPAIN OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 45. SPAIN OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 46. SPAIN OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 47. UK OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 48. UK OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 49. UK OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 50. RUSSIA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 51. RUSSIA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 52. RUSSIA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 53. REST OF EUROPE OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 54. REST OF EUROPE OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 55. REST OF EUROPE OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 56. ASIA-PACIFIC OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 57. ASIA-PACIFIC OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 58. ASIA-PACIFIC OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 59. ASIA-PACIFIC OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 60. CHINA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 61. CHINA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 62. CHINA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 63. JAPAN OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 64. JAPAN OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 65. JAPAN OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 66. INDIA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 67. INDIA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 68. INDIA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 69. SOUTH KOREA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 70. SOUTH KOREA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 71. SOUTH KOREA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 72. AUSTRALIA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 73. AUSTRALIA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 74. AUSTRALIA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 75. THAILAND OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 76. THAILAND OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 77. THAILAND OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 78. MALAYSIA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 79. MALAYSIA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 80. MALAYSIA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 81. INDONESIA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 82. INDONESIA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 83. INDONESIA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 84. REST OF ASIA PACIFIC OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 85. REST OF ASIA PACIFIC OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 86. REST OF ASIA PACIFIC OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 87. LAMEA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 88. LAMEA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 89. LAMEA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 90. LAMEA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 91. BRAZIL OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 92. BRAZIL OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 93. BRAZIL OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 94. SOUTH AFRICA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 95. SOUTH AFRICA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 96. SOUTH AFRICA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 97. SAUDI ARABIA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 98. SAUDI ARABIA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 99. SAUDI ARABIA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 100. UAE OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 101. UAE OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 102. UAE OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 103. ARGENTINA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 104. ARGENTINA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 105. ARGENTINA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 106. REST OF LAMEA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  DIAGNOSTIC, 2022-2032 ($MILLION)
  • TABLE 107. REST OF LAMEA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY  SURGICAL, 2022-2032 ($MILLION)
  • TABLE 108. REST OF LAMEA OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES, BY VISION CARE, 2022-2032 ($MILLION)
  • TABLE 109. BAUSCH AND LOMB, INC.: KEY EXECUTIVES
  • TABLE 110. BAUSCH AND LOMB, INC.: COMPANY SNAPSHOT
  • TABLE 111. BAUSCH AND LOMB, INC.: OPERATING SEGMENTS
  • TABLE 112. BAUSCH AND LOMB, INC.: PRODUCT PORTFOLIO
  • TABLE 113. BAUSCH AND LOMB, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 114. CARL ZEISS MEDITEC AG: KEY EXECUTIVES
  • TABLE 115. CARL ZEISS MEDITEC AG: COMPANY SNAPSHOT
  • TABLE 116. CARL ZEISS MEDITEC AG: OPERATING SEGMENTS
  • TABLE 117. CARL ZEISS MEDITEC AG: PRODUCT PORTFOLIO
  • TABLE 118. CARL ZEISS MEDITEC AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 119. COOPERVISION: KEY EXECUTIVES
  • TABLE 120. COOPERVISION: COMPANY SNAPSHOT
  • TABLE 121. COOPERVISION: OPERATING SEGMENTS
  • TABLE 122. COOPERVISION: PRODUCT PORTFOLIO
  • TABLE 123. COOPERVISION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 124. ESSILOR INTERNATIONAL: KEY EXECUTIVES
  • TABLE 125. ESSILOR INTERNATIONAL: COMPANY SNAPSHOT
  • TABLE 126. ESSILOR INTERNATIONAL: OPERATING SEGMENTS
  • TABLE 127. ESSILOR INTERNATIONAL: PRODUCT PORTFOLIO
  • TABLE 128. ESSILOR INTERNATIONAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 129. ABBOTT MEDICAL OPTICS, INC.: KEY EXECUTIVES
  • TABLE 130. ABBOTT MEDICAL OPTICS, INC.: COMPANY SNAPSHOT
  • TABLE 131. ABBOTT MEDICAL OPTICS, INC.: OPERATING SEGMENTS
  • TABLE 132. ABBOTT MEDICAL OPTICS, INC.: PRODUCT PORTFOLIO
  • TABLE 133. ABBOTT MEDICAL OPTICS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 134. ALCON LABORATORIES, INC.: KEY EXECUTIVES
  • TABLE 135. ALCON LABORATORIES, INC.: COMPANY SNAPSHOT
  • TABLE 136. ALCON LABORATORIES, INC.: OPERATING SEGMENTS
  • TABLE 137. ALCON LABORATORIES, INC.: PRODUCT PORTFOLIO
  • TABLE 138. ALCON LABORATORIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 139. HOYA CORPORATION: KEY EXECUTIVES
  • TABLE 140. HOYA CORPORATION: COMPANY SNAPSHOT
  • TABLE 141. HOYA CORPORATION: OPERATING SEGMENTS
  • TABLE 142. HOYA CORPORATION: PRODUCT PORTFOLIO
  • TABLE 143. HOYA CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 144. JOHNSON AND JOHNSON: KEY EXECUTIVES
  • TABLE 145. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
  • TABLE 146. JOHNSON AND JOHNSON: OPERATING SEGMENTS
  • TABLE 147. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
  • TABLE 148. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 149. TOPCON CORPORATION: KEY EXECUTIVES
  • TABLE 150. TOPCON CORPORATION: COMPANY SNAPSHOT
  • TABLE 151. TOPCON CORPORATION: OPERATING SEGMENTS
  • TABLE 152. TOPCON CORPORATION: PRODUCT PORTFOLIO
  • TABLE 153. TOPCON CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 154. SYNERGEYES: KEY EXECUTIVES
  • TABLE 155. SYNERGEYES: COMPANY SNAPSHOT
  • TABLE 156. SYNERGEYES: OPERATING SEGMENTS
  • TABLE 157. SYNERGEYES: PRODUCT PORTFOLIO
  • TABLE 158. SYNERGEYES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET
  • FIGURE 3. SEGMENTATION OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALOPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET
  • FIGURE 11. OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET SEGMENTATION, BY BY  DIAGNOSTIC
  • FIGURE 12. OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET FOR AUTOREFRACTOMETERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET FOR SLIT LAMPS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET FOR TONOMETERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET FOR OPHTHALMOSCOPES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET FOR FUNDUS CAMERAS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET FOR OPTICAL COHERENCE TOMOGRAPHY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET SEGMENTATION, BY BY  SURGICAL
  • FIGURE 20. OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET FOR VITREORETINAL SURGERY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET FOR CATARACT SURGERY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET FOR GLAUCOMA SURGERY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET FOR REFRACTIVE SURGERY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET SEGMENTATION, BY BY VISION CARE
  • FIGURE 25. OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET FOR CONTACT LENS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET FOR SPECTACLES LENSES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 27. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 28. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 29. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 30. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 31. COMPETITIVE DASHBOARD
  • FIGURE 32. COMPETITIVE HEATMAP: OPHTHALMOLOGY DIAGNOSTICS AND SURGICAL DEVICES MARKET
  • FIGURE 33. Top player positioning, 2022
  • FIGURE 34. BAUSCH AND LOMB, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 35. BAUSCH AND LOMB, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 36. BAUSCH AND LOMB, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 37. CARL ZEISS MEDITEC AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 38. CARL ZEISS MEDITEC AG: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 39. CARL ZEISS MEDITEC AG: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 40. COOPERVISION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 41. COOPERVISION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 42. COOPERVISION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 43. ESSILOR INTERNATIONAL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 44. ESSILOR INTERNATIONAL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 45. ESSILOR INTERNATIONAL: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 46. ABBOTT MEDICAL OPTICS, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 47. ABBOTT MEDICAL OPTICS, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 48. ABBOTT MEDICAL OPTICS, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 49. ALCON LABORATORIES, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 50. ALCON LABORATORIES, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 51. ALCON LABORATORIES, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 52. HOYA CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. HOYA CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 54. HOYA CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 55. JOHNSON AND JOHNSON: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 56. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 57. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 58. TOPCON CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 59. TOPCON CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 60. TOPCON CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 61. SYNERGEYES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 62. SYNERGEYES: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 63. SYNERGEYES: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
RELATED TAGS

Purchase Full Report of
Ophthalmology Diagnostics And Surgical Devices Market

Start reading.
This Report and over 67,132+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers